Antibiotic treatment of community-acquired and hospital-acquired pneumonia

被引：0
|
作者：
Simon, Susanne [1 ,3 ]
Rademacher, Jessica [1 ,2 ]
机构：
[1] Hannover Med Sch, Klin Pneumol & Infektiol, Hannover, Germany
[2] German Ctr Lung Res DZL, Biomed Res End Stage & Obstruct Lung Dis Hannover, Hannover, Germany
[3] Hannover Med Sch, Klin Pneumol & Infektiol, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源：
MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN | 2023年 / 118卷 / 06期
关键词：
Community-acquired pneumonia (CAP); Hospital-acquired pneumonia (HAP); Severe community-acquired pneumonia; Multiplex PCR; Duration of therapy; OUTCOMES; IMPACT;
D O I：
10.1007/s00063-023-01033-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Community-acquired and nosocomial bacterial pneumonia are among the most common infectious diseases in Germany. Knowledge of possible pathogens and therapeutic implications thereof are essential to be able to provide adequate, differentiated antimicrobial therapy with the appropriate drugs, form of application, dose, and duration. New diagnostics that include multiplex polymerase chain reaction, correct interpretation of the biomarker procalcitonin, and treatment of multidrug-resistant bacteria are becoming increasingly import.
引用
收藏
页码：454 / 463
页数：10
相关论文
共 50 条
  • [41] Treatment of community-acquired pneumonia
    Kolditz, M.
    Halank, M.
    Hoeffken, G.
    [J]. PNEUMOLOGE, 2005, 2 (01): : 34 - 41
  • [42] Treatment of community-acquired pneumonia
    Low, Donald E.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2008, 179 (12) : 1245 - 1246
  • [43] Treatment of community-acquired pneumonia
    Bartlett, J
    [J]. CHEMOTHERAPY, 2000, 46 : 24 - 31
  • [44] DIAGNOSTICS AND TREATMENT FAILS OF COMMUNITY-ACQUIRED PNEUMONIA IN HOSPITAL
    Fushtey, I. M.
    Savchenco, O. A.
    Podsevahina, S. L.
    Tkachenko, O., V
    [J]. WORLD OF MEDICINE AND BIOLOGY, 2015, 48 (01): : 85 - 88
  • [45] P24 Auditing antibiotic course lengths for the management of community-acquired pneumonia and hospital-acquired pneumonia against current NICE guidance
    Chua, Elaine
    Hearsey, Daniel
    [J]. JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (SUPP_2):
  • [46] Epidemiology and Outcomes in Community-Acquired Versus Hospital-Acquired AKI
    Wonnacott, Alexa
    Meran, Soma
    Amphlett, Bethan
    Talabani, Bnar
    Phillips, Aled
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 9 (06): : 1007 - 1014
  • [47] Treatment of community-acquired pneumonia
    Lee, Young R.
    Houngue, Coovi
    Hall, Ronald G.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (09) : 1109 - 1121
  • [48] Treatment of community-acquired pneumonia
    Giménez, RAFD
    [J]. MEDICINA CLINICA, 2003, 121 (01): : 36 - 36
  • [49] TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA
    LODE, H
    HOFFKEN, G
    KEMMERICH, B
    VOGELHARTMANN, H
    RAHLWES, M
    WAGNER, J
    RUCKDESCHEL, G
    EHRET, E
    [J]. ATEMWEGS-UND LUNGENKRANKHEITEN, 1988, 14 (02) : 89 - 92
  • [50] Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients
    Putot, A.
    Tetu, J.
    Perrin, S.
    Bailly, H.
    Piroth, L.
    Besancenot, J. -F.
    Bonnotte, B.
    Chavanet, P.
    d'Athis, P.
    Charles, P. -E.
    Sordet-Guepet, H.
    Manckoundia, P.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (03) : 489 - 495
12345